The Pharmacogenetics Roll Out – Gauging Response to Service [PROGRESS] programme is an NHS England funded transformation project led by researchers at Manchester University NHS Foundation Trust.
Read more
Patients across GM and the UK, will have greater access to cutting-edge treatments and clinical trials following a government announcement of £100m of private investment to set up local research hubs.
Read more
Recently the NIHR BRC and the NIHR North West Regional Research Delivery Network hosted the Greater Manchester Inflammation Showcase: Musculoskeletal Diseases (MSK) and Dermatology Focus event,
Read more
Greater Manchester residents are being encouraged to take part in a research study at MREH that aims to improve the diagnosis and treatment of conditions associated with sight loss.
Read more
Research delivered through the NIHR Manchester Biomedical Research Centre (BRC) has contributed to improved diagnostic guidelines for identifying and managing asthma, announced by NICE last week.
Read more
New research at Wythenshawe Hospital, has the potential to limit the development of antibiotic resistance while improving patient outcomes, when treating very ill patients with pneumonia and sepsis.
Read more
A ground-breaking genetic test that could prevent critically ill newborn babies going deaf if treated with a commonly used antibiotic, is being trialled across 14 NHS neonatal units.
Read more
On Tuesday 10 September 2024, MFT's Innovation Team brought together colleagues from across the NHS, academia and industry to showcase our innovation offer at MFT.
Read more
